Transmural Healing and Disease-Modifying Effect of Guselkumab in Crohn's Disease Patients

NCT ID: NCT06408935

This clinical trial is studying a medication called guselkumab to see how well it can help heal all layers of the digestive tract in patients with Crohn's disease. The goal is to achieve something ...

Recruiting

Phase: PHASE3 Conditions: Crohn's Disease

Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease

NCT ID: NCT06548542

This clinical trial is exploring new targeted therapies to treat adults with moderate to severe Crohn's Disease, a long-lasting condition that causes inflammation in the digestive tract and can lea...

Recruiting

Phase: PHASE2 Conditions: Crohn's Disease

PRospective phenotypIng and Multi-omic Endotyping of Progressive Pulmonary Fibrosis

NCT ID: NCT06855329

This clinical trial is studying a condition called Progressive Pulmonary Fibrosis (PPF), which is a form of lung disease that causes scarring and breathing difficulties. The goal of the study is to...

Recruiting

Conditions: Interstitial Lung Disease, Progressive Pulmonary Fibrosis

A Study Comparing BMS-986504 in Combination With Nab-paclitaxel and Gemcitabine Versus Placebo in Combination With Nab-paclitaxel and Gemcitabine in Participants With Untreated Metastatic Pancreatic Ductal Adenocarcinoma With Homozygous MTAP Deletion (MountainTAP-30)

NCT ID: NCT07076121

This clinical trial is studying a new treatment option for people with a type of advanced pancreatic cancer called metastatic pancreatic ductal adenocarcinoma (PDAC). Specifically, it’s looking at ...

Not yet recruiting

Phase: PHASE2 Conditions: Pancreatic Ductal Adenocarcinoma

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

NCT ID: NCT05564390

The MYELOMATCH trial is a research study designed to help people with certain types of blood cancers, specifically acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS). The main goal of ...

Recruiting

Phase: PHASE2 Conditions: Acute Myeloid Leukemia, Myelodysplastic Syndrome

Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)

NCT ID: NCT05183035

This clinical trial is studying the use of a medication called venetoclax in combination with chemotherapy to see if it can help children, adolescents, and young adults with relapsed acute myeloid ...

Recruiting

Phase: PHASE3 Conditions: Acute Myeloid Leukemia

A Study Comparing Teclistamab Monotherapy Versus Pomalidomide, Bortezomib, Dexamethasone (PVd) or Carfilzomib, Dexamethasone (Kd) in Participants With Relapsed or Refractory Multiple Myeloma

NCT ID: NCT05572515

This clinical trial is studying a new treatment called teclistamab for patients with relapsed or refractory multiple myeloma, which means their cancer has returned or has not responded to previous ...

Recruiting

Phase: PHASE3 Conditions: Relapsed or Refractory Multiple Myeloma

A Study of Milvexian in Participants After an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack- LIBREXIA-STROKE

NCT ID: NCT05702034

The LIBREXIA-STROKE trial is studying a new medication called milvexian to see if it can help prevent another ischemic stroke in people who have recently experienced one or a high-risk transient is...

Recruiting

Phase: PHASE3 Conditions: Ischemic Stroke; Ischemic Attack, Transient

A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome

NCT ID: NCT05754957

This clinical trial is studying a medication called milvexian to see if it can help reduce the risk of serious heart problems in patients who have recently experienced an acute coronary syndrome (A...

Recruiting

Phase: PHASE3 Conditions: Acute Coronary Syndrome

A Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib in Adult and Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa Who Have Failed Anti-TNF Therapy

NCT ID: NCT05889182

This clinical trial is studying a medication called upadacitinib to see how effective and safe it is for treating moderate to severe hidradenitis suppurativa (HS) in adults and adolescents who have...

Recruiting

Phase: PHASE3 Conditions: Hidradenitis Suppurativa

A Study Comparing Talquetamab Plus Pomalidomide, Talquetamab Plus Teclistamab, and Elotuzumab, Pomalidomide, and Dexamethasone or Pomalidomide, Bortezomib, and Dexamethasone in Participants With Relapsed or Refractory Myeloma Who Have Received an Anti-CD38 Antibody and Lenalidomide

NCT ID: NCT06208150

This clinical trial is studying the effectiveness of new combination treatments for patients with relapsed or refractory multiple myeloma, a type of blood cancer. Specifically, it compares two trea...

Recruiting

Phase: PHASE3 Conditions: Relapsed or Refractory Multiple Myeloma

VE303 for Prevention of Recurrent Clostridioides Difficile Infection

NCT ID: NCT06237452

The VE303 clinical trial is studying a new treatment called VE303 to see if it can help prevent repeated infections caused by Clostridioides difficile, often called C. diff. This trial is open to t...

Recruiting

Phase: PHASE3 Conditions: Clostridium Difficile, Clostridioides Difficile Infection +8 more

A Study of Tirzepatide in Adolescents With Obesity and Weight-Related Comorbidities (SURMOUNT-ADOLESCENTS-2)

NCT ID: NCT06439277

This clinical trial, called SURMOUNT-ADOLESCENTS-2, is studying a medication called tirzepatide to see how it helps adolescents with obesity and related health issues, like high blood pressure or p...

Recruiting

Phase: PHASE3 Conditions: Obesity, Weight Gain

A Study to Evaluate the Drug Levels, Efficacy and Safety of Deucravacitinib in Pediatric Participants With Moderate to Severe Plaque Psoriasis

NCT ID: NCT04772079

This clinical trial is studying a new medication called Deucravacitinib to see how well it works and how safe it is for children and teenagers aged 4 to under 18 years who have moderate to severe p...

Recruiting

Phase: PHASE3 Conditions: Plaque Psoriasis

A Study to Learn About the Study Medicine Elranatamab Alone and With Daratumumab in People With Multiple Myeloma Who Have Received Other Treatments

NCT ID: NCT05020236

The MagnetisMM-5 clinical trial is studying a new treatment option for people with relapsed or refractory multiple myeloma, a type of blood cancer. Researchers want to see if a medication called el...

Recruiting

Phase: PHASE3 Conditions: Multiple Myeloma

Pembrolizumab and Brentuximab Vedotin vs GDP and Stem Cell Transplant for Relapsed/Refractory Hodgkin Lymphoma

NCT ID: NCT05180097

This clinical trial is examining the effectiveness of two new drugs, Pembrolizumab and Brentuximab Vedotin, compared to standard treatments for patients with relapsed or refractory Hodgkin lymphoma...

Recruiting

Phase: PHASE2 Conditions: Hodgkin Lymphoma

A Randomized Trial of Five Fraction Partial Breast Irradiation (RAPID2)

NCT ID: NCT05417516

The RAPID2 trial is studying a treatment option for women with early-stage breast cancer. Specifically, it is comparing two types of radiation therapy: Partial Breast Irradiation (PBI), which targe...

Recruiting

Phase: PHASE3 Conditions: Radiotherapy, Breast Neoplasm Female +1 more

Disitamab Vedotin With Pembrolizumab vs Chemotherapy in Previously Untreated Urothelial Cancer Expressing HER2

NCT ID: NCT05911295

This clinical trial is studying two different treatment options for patients with urothelial cancer, which can affect the bladder, kidneys, or urinary tubes. The researchers want to find out if a c...

Recruiting

Phase: PHASE3 Conditions: Urothelial Carcinoma

Determine Effectiveness of Anifrolumab In SYstemic Sclerosis (DAISY)

NCT ID: NCT05925803

The DAISY clinical trial is studying the effectiveness and safety of a new treatment called anifrolumab for adults with systemic sclerosis, also known as scleroderma. This trial is specifically aim...

Recruiting

Phase: PHASE3 Conditions: Systemic Sclerosis, Scleroderma

Sacituzumab Tirumotecan (MK-2870) in Post Platinum and Post Immunotherapy Endometrial Cancer (MK-2870-005)

NCT ID: NCT06132958

This clinical trial is studying a new treatment called MK-2870, also known as sacituzumab tirumotecan, for women with endometrial cancer who have already received certain types of treatments. These...

Recruiting

Phase: PHASE3 Conditions: Endometrial Cancer

Main Menu

Clinical Trials in Calgary, Alberta

566 Active Trials Found in Calgary

Transmural Healing and Disease-Modifying Effect of Guselkumab in Crohn's Disease Patients

Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease

PRospective phenotypIng and Multi-omic Endotyping of Progressive Pulmonary Fibrosis

A Study Comparing BMS-986504 in Combination With Nab-paclitaxel and Gemcitabine Versus Placebo in Combination With Nab-paclitaxel and Gemcitabine in Participants With Untreated Metastatic Pancreatic Ductal Adenocarcinoma With Homozygous MTAP Deletion (MountainTAP-30)

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)

A Study Comparing Teclistamab Monotherapy Versus Pomalidomide, Bortezomib, Dexamethasone (PVd) or Carfilzomib, Dexamethasone (Kd) in Participants With Relapsed or Refractory Multiple Myeloma

A Study of Milvexian in Participants After an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack- LIBREXIA-STROKE

A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome

A Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib in Adult and Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa Who Have Failed Anti-TNF Therapy

A Study Comparing Talquetamab Plus Pomalidomide, Talquetamab Plus Teclistamab, and Elotuzumab, Pomalidomide, and Dexamethasone or Pomalidomide, Bortezomib, and Dexamethasone in Participants With Relapsed or Refractory Myeloma Who Have Received an Anti-CD38 Antibody and Lenalidomide

VE303 for Prevention of Recurrent Clostridioides Difficile Infection

A Study of Tirzepatide in Adolescents With Obesity and Weight-Related Comorbidities (SURMOUNT-ADOLESCENTS-2)

A Study to Evaluate the Drug Levels, Efficacy and Safety of Deucravacitinib in Pediatric Participants With Moderate to Severe Plaque Psoriasis

A Study to Learn About the Study Medicine Elranatamab Alone and With Daratumumab in People With Multiple Myeloma Who Have Received Other Treatments

Pembrolizumab and Brentuximab Vedotin vs GDP and Stem Cell Transplant for Relapsed/Refractory Hodgkin Lymphoma

A Randomized Trial of Five Fraction Partial Breast Irradiation (RAPID2)

Disitamab Vedotin With Pembrolizumab vs Chemotherapy in Previously Untreated Urothelial Cancer Expressing HER2

Determine Effectiveness of Anifrolumab In SYstemic Sclerosis (DAISY)

Sacituzumab Tirumotecan (MK-2870) in Post Platinum and Post Immunotherapy Endometrial Cancer (MK-2870-005)